Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Phencyclidine and marijuana exposure in utero
John O. Ogunbileje
, Paul E. Young
,
Anthony O. Okorodudu
Pathology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Phencyclidine and marijuana exposure in utero'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Phencyclidine
100%
Fetus
100%
Illicit Drugs
100%
Marijuana
100%
In Utero Exposure
100%
Immunoassay
100%
Tetrahydrocannabinol
100%
Abuse during Pregnancy
50%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
50%
Pregnant Women
50%
Developmental Defects
50%
Mass Spectrometry Methods
50%
Reference Laboratory
50%
Intrauterine Fetal Death
50%
Positive Check
50%
Meconium
50%
Selective Intrauterine Growth Restriction (sIUGR)
50%
Teratogenic
50%
Intrauterine Exposure
50%
Medicine and Dentistry
Immunoassay
100%
Cannabis
100%
Phencyclidine
100%
Tetrahydrocannabinol
100%
Drug Abuse
50%
Liquid Chromatography-Mass Spectrometry
50%
Meconium
50%
Intrauterine Growth Retardation
50%
Phencyclidine Abuse
50%
Pregnant Woman
50%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoassay
100%
Phencyclidine
100%
Cannabis
100%
Tetrahydrocannabinol
100%
Intrauterine Growth Retardation
50%